+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Intelligence in Oncology Market by Product Type, Technology, Deployment Mode, Cancer Type, Application, End-Use - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055601
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial intelligence in oncology market is redefining the future of cancer care, with innovative approaches integrating AI-driven diagnostics, treatment planning, and resource allocation across healthcare ecosystems worldwide.

Market Snapshot: Artificial Intelligence in Oncology Market

The Artificial Intelligence in Oncology Market grew from USD 2.54 billion in 2024 to USD 3.20 billion in 2025. With a projected CAGR of 27.14%, the market is on track to reach USD 10.72 billion by 2030. This growth reflects widespread demand for precision cancer care solutions that incorporate advanced machine learning, data analytics, and automation into diagnostic and therapeutic processes.

Scope & Segmentation

  • Product Type: Hardware (diagnostic imaging systems, robotic surgical systems), software solutions (cloud-based platforms, on-premise tools), consulting and implementation services
  • Technology: Computer vision (3D reconstruction, image recognition, video analysis), machine learning, natural language processing (data annotation, sentiment analysis, text mining), robotic process automation (automated workflows, process mapping)
  • Deployment Mode: Integrated systems, standalone AI tools
  • Cancer Type: Breast, cervical, colorectal, esophageal, liver, lung, skin, stomach (gastric), and thyroid cancer solutions
  • Application: Diagnostics (imaging analytics, molecular diagnostics, pathology), drug discovery (clinical trials design, lead discovery, target identification), outcome prediction (complication prediction, response prediction, survival rate visualization), personalized medicine (biomarker identification, genomic data analysis, therapeutic optimization), treatment planning (chemotherapy, surgical planning)
  • End-Use: Diagnostic laboratories (genomic testing facilities, pathology labs), hospitals (private, public), pharmaceutical companies (generic manufacturers, innovator companies), research institutions
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and other key markets), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)
  • Industry Players: Market activity includes organizations such as Amazon Web Services, GE Healthcare, Siemens Healthineers AG, Flatiron Health, Butterfly Network, Nvidia, Tempus AI, Paige.AI, PathAI, Medial EarlySign, among others

Key Takeaways

  • AI-driven oncology solutions foster early detection, personalized therapy, and workflow efficiency across the cancer care continuum.
  • Diagnostic imaging empowered by computer vision accelerates accurate identification of malignancies while robotic surgical innovations reduce recovery times and complications.
  • Robust cloud-based platforms and on-premise tools streamline multidisciplinary data exchange, supporting collaborative care and incorporating real-time insights throughout patient management.
  • Collaboration between healthcare providers, technology developers, and research institutions accelerates the validation and deployment of next-generation AI applications.
  • Segmented solutions for various cancer types enable tailored approaches, addressing the heterogeneous needs of oncology stakeholders worldwide.
  • Strategic alliances and targeted investments in R&D underpin a competitive landscape, fueling continual enhancement in clinical and operational outcomes.

Tariff Impact: Navigating 2025 Cost Pressures

New US tariffs introduced in 2025 have significantly affected hardware costs for diagnostic imaging and robotic surgical systems within the field. These changes prompted manufacturers to adopt local assembly, revise procurement strategies, and strengthen supply chain resilience. Software and service providers are mitigating pricing pressures by offering bundled consulting and flexible subscription models, ensuring ongoing adoption and market competitiveness despite evolving trade dynamics.

Methodology & Data Sources

This report synthesizes primary insights from oncology specialists, hospital administrators, payers, and technology developers. Secondary research leverages peer-reviewed journals, regulatory filings, and company reports. Analytical rigor is ensured through structured segmentation, comparative benchmarking, and thematic coding, aligning findings with evolving clinical and economic priorities.

Why This Report Matters

  • Enables executive decision-makers to prioritize investments, identify emerging risks, and seize technology-driven opportunities across regions and product categories.
  • Delivers actionable insights for adopting modular AI deployments, optimizing resource allocation, and enhancing patient outcomes in oncology care.
  • Equips stakeholders to navigate complexities such as tariff impact, regulatory shifts, and intensified competition in the evolving cancer care landscape.

Conclusion

The artificial intelligence in oncology market is positioned to transform cancer diagnostics, therapeutics, and care delivery. Strategic alignment across product, technology, and regional priorities can unlock significant value for healthcare leaders, technology innovators, and investors driving progress in oncology.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer cases globally necessitates innovative AI solutions to enhance care
5.1.1.2. Government initiatives and funding for AI research in healthcare drive innovation and adoption in oncology
5.1.2. Restraints
5.1.2.1. High costs associated with AI development and deployment along with interoperability issues
5.1.3. Opportunities
5.1.3.1. Significant partnerships between oncology care provider and AI technology providers
5.1.3.2. Surge in telemedicine and remote monitoring bolsters AI-enabled remote oncology services and care
5.1.4. Challenges
5.1.4.1. Challenges in ensuring fairness and mitigating biases in AI algorithms to provide equitable oncology care
5.2. Market Segmentation Analysis
5.2.1. Product Type: Significant development of the software solutions for data management and targeted decision-making
5.2.2. End-Use: Advancements in AI solutions to enhance production efficiencies and quality control measures for generic manufacturers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Artificial Intelligence in Oncology Market, by Product Type
6.1. Introduction
6.2. Hardware
6.2.1. Diagnostic Imaging Systems
6.2.2. Robotic Surgical Systems
6.3. Services
6.3.1. Consulting Services
6.3.2. Implementation Services
6.4. Software Solutions
6.4.1. Cloud-Based Solutions
6.4.2. On-Premise Tools
7. Artificial Intelligence in Oncology Market, by Technology
7.1. Introduction
7.2. Computer Vision
7.2.1. 3D Reconstruction
7.2.2. Image Recognition
7.2.3. Video Analysis
7.3. Machine Learning
7.3.1. Deep Learning
7.3.2. Supervised Learning
7.3.3. Unsupervised Learning
7.4. Natural Language Processing
7.4.1. Data Annotation
7.4.2. Sentiment Analysis
7.4.3. Text Mining
7.5. Robotic Process Automation
7.5.1. Automated Workflows
7.5.2. Clinical Documentation
7.5.3. Process Mapping
8. Artificial Intelligence in Oncology Market, by Cancer Type
8.1. Introduction
8.2. Breast Cancer
8.3. Cervical Cancer
8.4. Colorectal Cancer
8.5. Esophageal Cancer
8.6. Liver Cancer
8.7. Lung Cancer
8.8. Skin Cancer
8.9. Stomach (Gastric) Cancer
8.10. Thyroid Cancer
9. Artificial Intelligence in Oncology Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Imaging Analytics
9.2.2. Molecular Diagnostics
9.2.3. Pathology
9.2.4. Screening
9.3. Drug Discovery
9.3.1. Clinical Trials Design
9.3.2. Lead Discovery
9.3.3. Target Identification
9.4. Outcome Prediction
9.4.1. Complication Prediction
9.4.2. Response Prediction
9.4.3. Survival Rate Visualization
9.5. Personalized Medicine
9.5.1. Biomarker Identification
9.5.2. Genomic Data Analysis
9.5.3. Therapeutic Optimization
9.6. Treatment Planning
9.6.1. Chemotherapy Planning
9.6.2. Radiation Therapy Planning
9.6.3. Surgical Planning
10. Artificial Intelligence in Oncology Market, by End-Use
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Genomic Testing Facilities
10.2.2. Pathology Labs
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Pharmaceutical Companies
10.4.1. Generic Manufacturers
10.4.2. Innovator Companies
10.5. Research Institutions
10.5.1. Academic Institutions
10.5.2. Biotech Firms
11. Americas Artificial Intelligence in Oncology Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Artificial Intelligence in Oncology Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Artificial Intelligence in Oncology Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. Health Care Global Enterprises (HCG) collaborates with Accenture to revolutionize AI-driven cancer research and treatment
14.3.2. Strategic partnership between BioAI and Arbele aims to revolutionize cancer treatment with AI-driven biomarker models
14.3.3. Apollo’s AI-powered Precision Oncology Centre in Bengaluru revolutionizes cancer diagnosis and care
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 4. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC SURGICAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CLOUD-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ON-PREMISE TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY IMAGE RECOGNITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DATA ANNOTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SENTIMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TEXT MINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY AUTOMATED WORKFLOWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CLINICAL DOCUMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PROCESS MAPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY STOMACH (GASTRIC) CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CLINICAL TRIALS DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPLICATION PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESPONSE PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SURVIVAL RATE VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY GENOMIC DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY THERAPEUTIC OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RADIATION THERAPY PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY GENOMIC TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 159. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 161. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 162. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 163. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 165. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 166. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 167. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 168. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 169. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 172. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 173. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 174. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 175. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 177. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 178. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 179. CANADA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 182. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 186. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 187. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 188. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 189. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 190. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 193. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 194. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 195. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 196. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 197. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 266. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 268. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 270. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
TABLE 272. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 273. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
TABLE 274. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 275. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 279. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY OUTCOME PREDICTION, 2018-2030 (USD MILLION)
TABLE 280. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 281. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 282. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 283. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. CHINA ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Intelligence in Oncology market report include:
  • Amazon Web Services, Inc.
  • Berg LLC
  • Bristol-Myers Squibb Company
  • Butterfly Network, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Flatiron Health, Inc.
  • Freenome Holdings, Inc.
  • GE Healthcare
  • Google LLC by Alphabet Inc.
  • IBM Corporation
  • Intel Corporation
  • Koninklijke Philips N.V.
  • Medial EarlySign Ltd.
  • Microsoft Corporation
  • Nvidia Corporation
  • Oncora Medical, Inc.
  • Paige.AI Inc.
  • PathAI, Inc.
  • Siemens Healthineers AG
  • Tempus AI, Inc.
  • Ultromics Limited
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd.

Table Information